South Middlesex Times

At a recent event held at Rutgers New Jersey Medical School, experts discussed the ongoing challenges in HIV care and prevention despite global advances in treatment. The discussion took place during a World AIDS Day event themed “Collective Action: Sustain and Accelerate HIV Progress,” organized by the Infectious Diseases Practice (IDP) in collaboration with the Division of Adolescent and Young Adult Medicine (DAYAM).

Shobha Swaminathan, professor and director of HIV Services at Rutgers, highlighted persistent barriers such as stigma and discrimination that hinder access to care. She noted that while effective treatments have extended life expectancy for those living with HIV, aging poses new challenges, including social isolation and medication adherence difficulties due to mental health issues.

Swaminathan emphasized the need for innovative therapeutic approaches like injectable medications. "A recent study demonstrated that injectable medication was better than daily pills," she stated, even for patients with mental health and substance use histories. Additionally, a study on Lenacapavir injections showed promising results in preventing new infections among cis-gender women.

The event also underscored the importance of evolving healthcare infrastructure to meet changing needs. Swaminathan expressed optimism about long-acting medications allowing individuals to live normally without being tied to daily pills.

Discussing IDP's efforts, Swaminathan explained their patient-centered model offering comprehensive care through various integrated programs such as gender-affirming care and substance use disorder counseling. Nearly 90 percent of their patients receive successful treatment.

Dominga Padilla from DAYAM highlighted their focus on youth aged 13 to 29 since 1976. Their efforts include providing counseling, testing, immediate access to care, and education for high-risk negative youth.

Jamir Tuten stressed that despite advancements in research and treatment, stigma continues to impede progress. "Ongoing research is crucial for improving lives," he said, advocating for education and better access to care as essential components in combating HIV globally.